Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Biogen Idec (NQ:BIIB)

202.58 +3.43 (+1.72%)
Streaming Delayed Price Updated: 12:38 PM EDT, Jul 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Biogen Idec

< Previous 1 2 3 4 5 6 7 8 9
...
50 51 Next >
News headline image
1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have be... 
Via StockStory
News headline image
2 Fast-Growing Pharmaceutical Stocks to Buy Now ↗
Incyte and TG Therapeutics are seeing strong share growth, backed up by booming revenue and earnings. 
Via The Motley Fool
News headline image
Biogen Is Paying $1 Billion for a Company That Won't Say What It Makes. Here's Why That's Actually Good News for BIIB Investors. ↗
This could be a key move for future growth. 
Via The Motley Fool
Topics Intellectual Property
Unusual volume S&P500 stocks in Thursday's session ↗
Via Chartmill
News headline image
1 S&P 500 Stock with Promising Prospects and 2 We Question
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch... 
Via StockStory
Topics Energy Stocks
News headline image
Why Biogen (BIIB) Stock Is Up Today
What Happened? Shares of biotech company Biogen (NASDAQ:BIIB) jumped 5.6% in the afternoon session after investors continued to cheer a string of growth sign... 
Via StockStory
Topics Artificial Intelligence Earnings
News headline image
Therapeutics Stocks Q1 Recap: Benchmarking Biogen (NASDAQ:BIIB)
Let’s dig into the relative performance of Biogen (NASDAQ:BIIB) and its peers as we unravel the now-completed Q1 therapeutics earnings season. Over the next ... 
Via StockStory
Topics Artificial Intelligence
News headline image
3 Overrated Stocks Walking a Fine Line
The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, pos... 
Via StockStory
News headline image
1 Cash-Producing Stock with Impressive Fundamentals and 2 We Find Risky
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient... 
Via StockStory
News headline image
Revolution Medicines Is Up 97% This Year: Here Are the Bull and Bear Cases for This Soaring Biotech Stock. ↗
Can the drugmaker justify its valuation? 
Via The Motley Fool
News headline image
MarketBeat Week in Review – 05/18 - 05/22 ↗
Stocks were up sharply to end the week as NVIDIA’s forward guidance showed tangible demand to support AI infrastructure and overshadowed mixed retail reports 
Via MarketBeat
Topics Artificial Intelligence Economy
News headline image
Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish ↗
Biogen’s Alzheimer’s drug candidate showed promising tau-targeting results despite missing a primary endpoint, reinforcing long-term optimism for BIIB stock 
Via MarketBeat
News headline image
Biogen Conference: Lupus, Kidney Programs Take Center Stage in Immunology Push ↗
Biogen (NASDAQ:BIIB) is continuing to position immunology as a larger part of its strategy, with late-stage lupus and kidney disease programs expected to shape the company’s next phase of growth, Adam... 
Via MarketBeat
Stay informed with the top movers within the S&P500 index on Thursday. ↗
Via Chartmill
News headline image
Best Healthcare Stocks to Buy in 2026 ↗
Novo Nordisk and Biogen are underpriced and stand to gain from new indications for their blockbuster therapies. 
Via The Motley Fool
Thursday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
These S&P500 stocks are gapping in today's session ↗
Via Chartmill
Discover the top S&P500 movers in Thursday's pre-market session. ↗
Via Chartmill
News headline image
3 Healthcare Stocks We’re Skeptical Of
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-... 
Via StockStory
News headline image
3 Value Stocks We Approach with Caution
Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built the... 
Via StockStory
News headline image
Biogen Analysts Boost Their Forecasts Following Upbeat Q1 Earnings ↗
Biogen (NASDAQ:BIIB) reported strong Q1 earnings, beating expectations. However, they cut their FY2026 EPS guidance. Analysts have mixed opinions on buying BIIB stock. 
Via Benzinga
News headline image
Why Biogen Stock Was a Winner on Wednesday ↗
The biotech's growth portfolio continues to add to its overall top line. 
Via The Motley Fool
News headline image
Biogen (BIIB) Q1 2026 Earnings Transcript ↗
Biogen (BIIB) Q1 2026 Earnings Transcript 
Via The Motley Fool
News headline image
Biogen (NASDAQ:BIIB) Surprises With Q1 CY2026 Sales
Biotech company Biogen (NASDAQ:BIIB) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 1.9% year on year to $2.48 billion. Its... 
Via StockStory
Topics Artificial Intelligence
News headline image
Biogen (BIIB) Reports Earnings Tomorrow: What To Expect
Biotech company Biogen (NASDAQ:BIIB) will be reporting results this Wednesday before the bell. Here’s what you need to know. Biogen beat analysts’ revenue ex... 
Via StockStory
Topics Artificial Intelligence
News headline image
3 Profitable Stocks We Steer Clear Of
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ... 
Via StockStory
News headline image
Biogen (BIIB) Q4 2024 Earnings Call Transcript ↗
Biogen (BIIB) Q4 2024 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Biogen (BIIB) Q3 2024 Earnings Transcript ↗
Biogen (BIIB) Q3 2024 Earnings Transcript 
Via The Motley Fool
News headline image
Biogen (BIIB) Q2 2025 Earnings Transcript ↗
Biogen (BIIB) Q2 2025 Earnings Transcript 
Via The Motley Fool
News headline image
Biogen (BIIB) Q3 2025 Earnings Transcript ↗
Biogen (BIIB) Q3 2025 Earnings Transcript 
Via The Motley Fool
Topics Economy
< Previous 1 2 3 4 5 6 7 8 9
...
50 51 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.